AGL - ANGLE - Share Chat

ANGLE PLC is a UK-based medical technology company focused on developing and commercialising its proprietary Parsortix® liquid biopsy system. This platform is designed to capture and harvest circulating tumour cells (CTCs) from patient blood samples, offering a non-invasive alternative for cancer research, drug development, and potential diagnostic applications.

The company’s strategy revolves around selling its Parsortix instruments and consumable cassettes globally, supported by strategic collaborations with pharmaceutical companies and leading research institutions. A significant milestone was achieving FDA de novo clearance for metastatic breast cancer. ANGLE is positioned as a key innovator in the precision medicine space, aiming to establish its technology as a standard for CTC-based analysis, although it currently operates in a pre-profitability stage, requiring ongoing investment in R&D and market expansion.